Stephen Garbacz

Head, Finance at Tessera Therapeutics

Steve Garbacz joined Tessera in 2021 as the Head of Finance and is responsible for financial reporting, planning, taxes, and treasury.

Steve has more than 25 years of experience in financial management for a range of companies, including Biogen, Epizyme, Spero, and Anika. He has a passion for building scalable financial organizations leveraging new technology and drove successful IPOs at Epizyme and Spero. At Anika, Steve was a key leader in acquiring and integrating two private companies.

Steve has a B.S. in Economics from George Mason University and an M.B.A. in Finance from the Leonard Stern School of Business at New York University.

Links

Previous companies

Biogen logo
Anika Therapeutics logo
Mondelez International logo
Spero Therapeutics logo

Timeline

  • Head, Finance

    Current role

View in org chart